Somnomed finds UK distribution partner
Tuesday, 08 July, 2008
Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.
Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.
The UK is generally considered to be one of the most important sleep therapy markets in Europe.
Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
